News

Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...
Trump HHS ends nearly $1 billion in funding to Moderna for mRNA bird flu vaccines, citing safety concerns and lack of ...
Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were ...
This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they ...
A new material developed at Cornell University could significantly improve the delivery and effectiveness of mRNA vaccines by ...
We recently published a list of Jim Cramer Talked About These 13 Stocks. In this article, we are going to take a look at ...
NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.
With COVID cases rising in India and several other countries, many people are wondering whether they should get vaccinated.
A new material developed at Cornell University could significantly improve the delivery and effectiveness of mRNA vaccines by ...
Moderna, Inc. (NASDAQ: MRNA) announced today that its investigational H5 avian influenza vaccine, mRNA-1018, has shown ...
The Trump administration on Wednesday canceled a $766 million contract with Moderna that funded efforts to develop a vaccine ...
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...